FDA Device recall Z-1128-2020
NC TREK Coronary Dilatation Catheter, REF 1012453-08 Rx Only, NC TREK RX 4.00 X 8MM BDC The NC TREK RX Coronary Dilatation Catheter is indi…
- FDA Device
- Class I
- terminated
- Published 2020-02-26
On 2020-02-26 the FDA classified a Class I recall of NC TREK Coronary Dilatation Catheter, REF 1012453-08 Rx Only, NC TREK RX 4.00 X 8MM BDC The NC TREK RX Coronary Dilatation Catheter is indi… by Abbott Vascular, citing coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1128-2020 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-01-29 |
| Published | 2020-02-26 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Abbott Vascular |
| Distribution | n/a |
Product
NC TREK Coronary Dilatation Catheter, REF 1012453-08 Rx Only, NC TREK RX 4.00 X 8MM BDC The NC TREK RX Coronary Dilatation Catheter is indicated for: a) balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis, for the purpose of improving myocardial perfusion b) balloon dilatation of a coronary artery occlusion, for the purpose of restoring coronary flow in patients with ST-segment elevation myocardial infarction c) balloon dilatation of a stent after implantation (balloon models 2.00 mm 5.00 mm only)
Reason
Coronary Dilatation Catheters may exhibit difficulty or inability to deflate the balloon.
Identifiers
| code_info | Device Identifier/GTIN:08717648152054 Part Number: 1012453-08 Lot Numbers: 90731G1 90921G1 90808G1 90928G1 90826G1 91003G1 90906G1 91017G1 91106G1 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1128-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.